These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33654427)

  • 41. College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer.
    Chen HY; Feng LL; Li M; Ju HQ; Ding Y; Lan M; Song SM; Han WD; Yu L; Wei MB; Pang XL; He F; Liu S; Zheng J; Ma Y; Lin CY; Lan P; Huang MJ; Zou YF; Yang ZL; Wang T; Lang JY; Orangio GR; Poylin V; Ajani JA; Wang WH; Wan XB
    Oncologist; 2021 May; 26(5):e780-e793. PubMed ID: 33543577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.
    Li Y; Jia H; Yu W; Xu Y; Li X; Li Q; Cai S
    Int J Cancer; 2016 Jul; 139(1):220-31. PubMed ID: 26933932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nomogram for predicting pathological complete response and tumor downstaging in patients with locally advanced rectal cancer on the basis of a randomized clinical trial.
    Zhang JW; Cai Y; Xie XY; Hu HB; Ling JY; Wu ZH; Lan P; Wu XJ; Huang MJ; Wang H; Kang L; Zhou ZY; Wang JP; Deng YH
    Gastroenterol Rep (Oxf); 2020 Jun; 8(3):234-241. PubMed ID: 32665855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
    Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
    Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
    Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
    Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nomograms for predicting overall and recurrence-free survival after trimodality therapy for esophageal adenocarcinoma.
    Merritt RE; Abdel-Rasoul M; Souza DM; Kneuertz PJ
    J Surg Oncol; 2021 Mar; 123(4):881-890. PubMed ID: 33333590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome.
    Jalilian M; Davis S; Mohebbi M; Sugamaran B; Porter IW; Bell S; Warrier SK; Wale R
    J Gastrointest Oncol; 2016 Aug; 7(4):603-8. PubMed ID: 27563451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nomograms for predicting recurrence and survival of invasive pathological stage IA non-small cell lung cancer treated by video assisted thoracoscopic surgery lobectomy.
    Chen H; Sui X; Yang F; Liu J; Wang J
    J Thorac Dis; 2017 Apr; 9(4):1046-1053. PubMed ID: 28523159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma.
    Squires MH; Ethun CG; Donahue EE; Benbow JH; Anderson CJ; Jagosky MH; Salo JC; Hill JS; Ahrens W; Prabhu RS; Livingston MB; Gower NL; Needham M; Trufan SJ; Fields RC; Krasnick BA; Bedi M; Abbott DE; Schwartz P; Votanopoulos K; Chouliaras K; Grignol V; Roggin KK; Tseng J; Poultsides G; Tran TB; Cardona K; Howard JH
    J Surg Oncol; 2021 Oct; 124(5):829-837. PubMed ID: 34254691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and Validation of a Four Adenosine-to-Inosine RNA Editing Site-Relevant Prognostic Signature for Assessing Survival in Breast Cancer Patients.
    Wan J; Chen S; Zhang A; Liu Y; Zhang Y; Li Q; Yu Z; Wan Y; Yang L; Wang Q
    Front Oncol; 2022; 12():861439. PubMed ID: 35494026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach.
    Lin JX; Wang ZK; Hong QQ; Zhang P; Zhang ZZ; He L; Wang Q; Shang L; Wang LJ; Sun YF; Li ZX; Liu JJ; Ding FH; Lin ED; Fu YA; Lin SM; Xie JW; Li P; Zheng CH; Huang CM
    JAMA Netw Open; 2021 Oct; 4(10):e2128217. PubMed ID: 34609494
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Models Based on Dynamic Clinicopathological Indices for Predicting Prognosis During the Perioperative Period for Patients with Colorectal Cancer.
    Ma Y; Lu P; Liang X; Wei S
    J Inflamm Res; 2021; 14():1591-1601. PubMed ID: 33907439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does Adjuvant Chemotherapy for Locally Advanced Resectable Rectal Cancer treated with Neoadjuvant Chemoradiotherapy have an impact on survival? A Single Moroccan Institute Retrospective Study.
    Seddik Y; Brahmi SA; Afqir S
    Gulf J Oncolog; 2019 May; 1(30):29-32. PubMed ID: 31242979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel nomogram with preferable capability in predicting the overall survival of patients after radical esophageal cancer resection based on accessible clinical indicators: A comparison with AJCC staging.
    Li X; Xu J; Zhu L; Yang S; Yu L; Lv W; Hu J
    Cancer Med; 2021 Jul; 10(13):4228-4239. PubMed ID: 34128338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel LARCassigner3 classification predicts outcomes in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: a retrospective training and validation analysis.
    Zhang J; Shen L; Deng Y; Sun X; Wang Y; Yao Y; Zhang H; Zou W; Zhang Z; Wan J; Yang L; Zhu J; Zhang Z
    Cancer Manag Res; 2019; 11():4153-4170. PubMed ID: 31123421
    [No Abstract]   [Full Text] [Related]  

  • 56. [Establishment of a prognostic nomogram to predict long-term survival in non-metastatic colorectal cancer patients].
    Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):654-659. PubMed ID: 28643310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiomic signature-based nomogram to predict disease-free survival in stage II and III colon cancer.
    Yao X; Sun C; Xiong F; Zhang X; Cheng J; Wang C; Ye Y; Hong N; Wang L; Liu Z; Meng X; Wang Y; Tian J
    Eur J Radiol; 2020 Oct; 131():109205. PubMed ID: 32871292
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact factors of lymph node retrieval on survival in locally advanced rectal cancer with neoadjuvant therapy.
    Mei SW; Liu Z; Wang Z; Pei W; Wei FZ; Chen JN; Wang ZJ; Shen HY; Li J; Zhao FQ; Wang XS; Liu Q
    World J Clin Cases; 2020 Dec; 8(24):6229-6242. PubMed ID: 33392304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and validation of prognostic nomogram for germ cell testicular cancer patients.
    Mao W; Wu J; Kong Q; Li J; Xu B; Chen M
    Aging (Albany NY); 2020 Nov; 12(21):22095-22111. PubMed ID: 33136554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survival Nomograms after Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer.
    Marchetti C; De Felice F; Di Pinto A; Romito A; Musella A; Palaia I; Monti M; Tombolin V; Muzii L; Benedetti Panici P
    Cancer Res Treat; 2018 Jul; 50(3):768-776. PubMed ID: 28724282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.